Brief: Impel Pharmaceuticals Announces First Quarter 2023 Financial Results
12/05/2023 13:43
May 12 (Reuters) - Impel Pharmaceuticals Inc IMPL.O :
* IMPEL PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* IMPEL PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $1.27
Source text for Eikon: ID:nGNX68H2Cq
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq